证券代码：603363 证券简称：傲农生物 公告编号：2025-114 福建傲农生物科技集团股份有限公司 关于召开2025年第四次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： (一)股东会类型和届次 2025年第四次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025年12月26日 14 点00 分 召开地点：福建省漳州市芗城区石亭镇兴亭路与宝莲路交叉处公司福建傲农会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025年12月26日 至2025年12月26日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股东会召开当日的交易时间 段，即9:15-9:25，9:30-11:30，13:00-15:00；通过互联网投票平台的投票时间为股东会召开当日的9:15- 15:00。 (六) ...

Group 1 - Weidi Co., Ltd. plans to acquire control of Jiuxing Precision Technology, which is expected to constitute a major asset restructuring. The company will pay cash to acquire 51% of the equity from Jiangsu Zhiyue Tiancheng Enterprise Management Co., Ltd. and Jiuxing Precision Technology, aiming to gain at least 51% voting rights [2] - Purun Co., Ltd. intends to purchase 49% equity of high-performance storage company Noah Changtian through issuing shares, convertible bonds, and cash payments. Upon completion, Purun will hold 100% of Noah Changtian, which specializes in high-performance 2D NAND and derivative storage products [3] - ST Yishite is undergoing a significant share transfer, with Jiangjiang Industrial Group acquiring 4.34 billion shares, representing 18.66% of the total share capital, at a price of 5.61 yuan per share, totaling 2.437 billion yuan [5] Group 2 - Midea Group has completed its share repurchase plan, buying back 135 million shares, accounting for 1.76% of the total share capital, with a total expenditure of approximately 10 billion yuan [6] - Jingji Agricultural plans to repurchase shares using self-raised funds, with a total amount between 100 million and 200 million yuan, at a maximum price of 23.7 yuan per share [6] - Helen Zhe intends to repurchase shares with a total amount between 50 million and 100 million yuan, at a maximum price of 7.5 yuan per share [7] Group 3 - Shengda Resources plans to acquire 60% equity of Yichun Jinshi Mining for 500 million yuan, which will become a subsidiary after the transaction [7] - Guangju Energy is participating in the public transfer of an 8% stake in Shenzhen Mawan Power, aiming to increase its holding from 6.42% to 14.42% [8] - Zhongrong Marine plans to invest 2.58 billion yuan in Guangdong Yantian Port for a 20% stake through its wholly-owned subsidiary [15]

Group 1 - Cambridge Technology plans to invest 400 million yuan to establish a fund focused on optical devices and chips, aiming to invest in early-stage and growth-stage companies in the hard technology sector [1] - Tunnel Corporation's consortium won a bid for a highway project in Henan with a total investment of 6.49 billion yuan, using a BOT model for a 33.25-year cooperation period [2] - Hongrun Construction won a bid for a project worth 230 million yuan, which represents 3.88% of the company's projected revenue for 2024 [3] Group 2 - Tongrentang's product, Canling Baizhu Powder, received product registration approval from Health Canada, aimed at treating symptoms related to spleen and stomach weakness [4] - Hunan Baiyin announced a scheduled annual maintenance from December 9, 2025, to January 5, 2026, for equipment and facilities [5] - Changchun Gaoxin's subsidiary had two drugs included in the national medical insurance catalog for 2025 [6] Group 3 - Dongfang Securities' chairman resigned due to work relocation [7] - Xuantai Pharmaceutical's product, Sitagliptin Metformin Sustained-Release Tablets, was renewed for inclusion in the national medical insurance catalog [8] - ST Weihai was pre-selected for a smart agriculture EPC project with a bid of 652 million yuan, accounting for 26.27% of the company's projected revenue for 2024 [9] Group 4 - Guoxin Technology successfully tested an anti-quantum password financial POS chip, supporting both traditional and quantum-resistant algorithms [10] - Huaren Health's subsidiary received acceptance for a drug registration application for Lactulose Oral Solution, a common laxative [11] - Ankai Bus reported a 57.71% year-on-year increase in sales for the first 11 months of the year [12] Group 5 - Zhongyan Dadi's subsidiary won a bid for a project worth 73.86 million yuan [13] - Zhejiang Rongtai plans to invest 77 million USD in a factory in Thailand, focusing on mica paper and robot components production [14] - Optoelectronics plans to use up to 450 million yuan of idle funds for cash management [15] Group 6 - Tianyu Biological reported a 45.15% year-on-year decline in sales revenue from pig sales in November [16] - Daqin Railway's cargo transport volume increased by 1.75% year-on-year in November [17] - Yabo Co. won a bid for a heavy truck charging station project worth 3.616 million yuan [18] Group 7 - Hongri Pharmaceutical's product continues to be included in the national medical insurance catalog [19] - Jinggong Steel Structure signed a contract for steel structure installation worth approximately 470 million yuan for an overseas project [20] - Xizang Pharmaceutical's product, Xinhuasuan, continues to be included in the national medical insurance catalog [21] Group 8 - Guangdong Electric Power A announced the successful commissioning of a 1000MW unit at the Maoming Boge Power Plant [22] - Fuan Pharmaceutical's product, Palivizumab Injection, was newly included in the national medical insurance catalog [23] - Lizhu Group reported that 194 products were included in the 2025 national medical insurance catalog [24] Group 9 - Haisan Pharmaceutical's injection of Lantanol was included in the national medical insurance catalog [25] - Zhongtong Bus reported a 39.53% year-on-year increase in sales volume in November [26] - Shaanxi Coal Industry reported a 6.03% year-on-year increase in coal production in November [27] Group 10 - Haooubo's subsidiary received a medical device registration certificate for an IgG4 testing kit [28] - Yaopi Glass plans to invest 690 million yuan in new automotive glass production lines [30] - Huadian International completed the issuance of 2 billion yuan in medium-term notes [31] Group 11 - Zhongzai Zihuan's subsidiary won a bid for a green recycling project worth 205 million yuan [32] - Dabeinong reported a 25.26% year-on-year decline in sales revenue from pig sales in November [33] - Xiangjia Co. reported a 3.77% year-on-year increase in live poultry sales revenue in November [34] Group 12 - Huanxu Electronics reported a consolidated revenue of 5.198 billion yuan in November, a decrease of 3.34% year-on-year [35] - Aonong Biological reported a 72.21% year-on-year increase in pig sales volume in November [36] - Samsung Medical's subsidiary was pre-selected for a procurement project worth approximately 108 million yuan [37]

傲农生物（603363）(603363.SH)发布11月养殖业务主要经营数据，2025年11月，公司生猪销售量15.77 万头，同比增加72.21%，较2025年10月减少17.08%。11月末，公司生猪存栏69.97万头，同比增加 33.94%，较2025年10月末增加7.58%，较2024年12月末增加36.41%。 ...

智通财经APP讯，傲农生物(603363.SH)发布11月养殖业务主要经营数据，2025年11月，公司生猪销售量 15.77万头，同比增加72.21%，较2025年10月减少17.08%。11月末，公司生猪存栏69.97万头，同比增加 33.94%，较2025年10月末增加7.58%，较2024年12月末增加36.41%。 ...

证券代码：603363 证券简称：傲农生物 公告编号：2025-113 福建傲农生物科技集团股份有限公司 2025 年 11 月养殖业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 主要产品 | 销售量 | 库存量 | 销售量同比 增减（%） | 库存量同比 增减（%） | | --- | --- | --- | --- | --- | | 生猪 | 15.77 | 69.97 | +72.21 | +33.94 | 2025 年 11 月，公司生猪销售量 15.77 万头，同比增加 72.21%，较 2025 年 10 月减少 17.08%。 2025 年 11 月末，公司生猪存栏 69.97 万头，同比增加 33.94%，较 2025 年 10 月末增加 7.58%，较 2024 年 12 月末增加 36.41%。 公司积极推动生猪养殖产能优化工作，合理调整养殖布局、规模与品种结构， 后续将继续坚持"稳字当头、持续降本"的策略，集中资源发展优势产能，务实 经营发展目标，切实推进降本工作。 二、其他说 ...

证券代码：603363 证券简称：傲农生物 公告编号：2025-114 福建傲农生物科技集团股份有限公司 关于召开2025年第四次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (二) 股东会召集人：董事会 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 一、 召开会议的基本情况 (一) 股东会类型和届次 2025年第四次临时股东会 召开的日期时间：2025 年 12 月 26 日 14 点 00 分 召开地点：福建省漳州市芗城区石亭镇兴亭路与宝莲路交叉处公司福建傲农 会议室 (五) 网络投票的系统、起止日期和投票时间。 股东会召开日期：2025年12月26日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 12 月 26 日 至2025 年 12 月 26 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为 ...

公司积极推动生猪养殖产能优化工作，合理调整养殖布局、规模与品种结构，后续将继续坚持"稳字当 头、持续降本"的策略，集中资源发展优势产能，务实经营发展目标，切实推进降本工作。 格隆汇12月8日丨傲农生物（维权）(603363.SH)公布，2025年11月，公司生猪销售量15.77万头，同比增 加72.21%，较2025年10月减少17.08%。2025年11月末，公司生猪存栏69.97万头，同比增加33.94%，较 2025年10月末增加7.58%，较2024年12月末增加36.41%。 ...

证券代码：603363 证券简称：傲农生物 公告编号：2025-109 福建傲农生物科技集团股份有限公司 关于2026年度与控股股东关联方 日常关联交易预计的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本关联交易事项已经公司第四届董事会第二十次会议审议通过，关联董事已回避表决，尚需提交公司 股东会审议。 ● 本次预计的日常关联交易不影响公司的独立性，公司的主营业务不会因此类交易而对关联人形成依 赖。 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 1、独立董事专门会议事先审议情况 福建傲农生物科技集团股份有限公司（以下简称"公司"）独立董事专门会议对本议案进行了事前审议， 认为：公司2026年度日常关联交易预计以2026年经营计划为基础，符合公司重整后的实际情况，有利于 促进公司的持续发展，2026年度日常关联交易预计以市场价格为基础，遵循公平合理的定价原则，不存 在损害公司及中小股东利益的情形，不会对公司独立性造成不利影响，不会因此而对关联方形成依赖。 因此，一致同意将关于2026年 ...

Group 1 - The company held its 20th meeting of the 4th Board of Directors on December 4, 2025, with all 9 directors present, and the meeting was conducted in accordance with relevant laws and regulations [2][3][4] - The board approved the proposal to waive the notice period for this board meeting with unanimous consent [3][4] - The board approved a financing credit limit application for 2026, allowing the company to apply for up to RMB 3 billion from financial institutions, which requires shareholder approval [5][6] Group 2 - The board approved a proposal to provide guarantees for industry chain partners in 2026, with a maximum guarantee amount of RMB 300 million, also pending shareholder approval [7][11] - The company authorized the general manager to allocate guarantee amounts within the approved limit and to sign relevant legal documents [8][9][10] - The board approved mutual guarantees among the company and its subsidiaries for 2026, with specific limits based on the subsidiaries' debt ratios, pending shareholder approval [11][56] Group 3 - The board approved expected daily related party transactions with controlling shareholders for 2026, with 5 votes in favor and no opposition [13][15] - The board also approved expected daily related party transactions with other related parties for 2026, with 8 votes in favor [16][20] - The board approved a proposal for hedging activities in 2026, allowing for a maximum margin and premium limit of RMB 85 million, with a maximum contract value of RMB 550 million [22][23] Group 4 - The board approved the nomination of a new independent director to replace the resigned director, pending approval from the Shanghai Stock Exchange and shareholders [24][28] - The board agreed to convene the 4th extraordinary shareholders' meeting of 2025 at a later date, with details to be announced [25][26] Group 5 - The company plans to provide guarantees for industry chain partners in 2026, with a maximum guarantee amount of RMB 300 million, to support business operations and maintain supply chain stability [33][35] - As of October 31, 2025, the company had actual guarantees of RMB 93.96 million for industry chain partners, with overdue guarantees amounting to RMB 275.82 million [34][49] - The company will implement risk control measures, including requiring guarantees from the partners and regular financial reporting [44][45]